Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action

NCT02060396 is registered in ClinicalTrials.gov with Aragon Institute of Health Sciences as lead sponsor.

NCT NCT02060396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02060396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action
Lead sponsor
Aragon Institute of Health Sciences
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2013
Completion date
December 31, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers